Scopus BioPharma News

Scopus BioPharma | 1-Z: Others

Feb 9 17:22 ET

Scopus BioPharma | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)

Jan 19 00:00 ET

Scopus BioPharma | 8-K: Current report

Aug 18, 2023 17:16 ET

Scopus BioPharma | 8-K: Current report

Aug 11, 2023 17:01 ET

Scopus BioPharma | 10-Q: Q2 2023 Earnings Report

Aug 11, 2023 17:00 ET

Scopus BioPharma | DEF 14A: Definitive information statements

Jul 21, 2023 17:00 ET

Scopus BioPharma | PRER14A: Preliminary revised proxy soliciting materials

Jun 28, 2023 17:16 ET

Scopus BioPharma | 10-Q: Q1 2023 Earnings Report

May 12, 2023 17:15 ET

Scopus BioPharma | 10-K/A: Annual report (Amendment)

Apr 28, 2023 17:00 ET

Scopus BioPharma | 10-K: FY2022 Annual Report

Apr 14, 2023 17:00 ET

Scopus BioPharma | NT 10-K: Others

Mar 31, 2023 17:00 ET

Scopus BioPharma | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

Mar 3, 2023 10:47 ET

Scopus BioPharma | 8-K: Current report

Dec 16, 2022 06:05 ET

Scopus BioPharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Dec 2, 2022 17:16 ET

Scopus BioPharma | 8-K: Current report

Dec 2, 2022 17:15 ET

Scopus BioPharma | 10-Q: Q3 2022 Earnings Report

Nov 21, 2022 17:16 ET

Scopus BioPharma | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Nov 15, 2022 17:15 ET

Scopus BioPharma | 8-K: Current report

Oct 20, 2022 17:15 ET

Scopus BioPharma | 8-K: Current report

Oct 19, 2022 09:15 ET

Scopus BioPharma | 8-K: Current report

Oct 7, 2022 17:16 ET